Add to Watchlist Create Alerts

Real-Time Last Update

Volume

MediPharm Labs Completes Sale of Vacant Land for Cash Proceeds of $1.9 million

PR Newswire - Tue Sep 5, 2023

TORONTO, Sept. 5, 2023 /PRNewswire/ - MediPharm Labs Corp. (TSX: LABS) (OTCQB: MEDIF) (FSE: MLZ) ("MediPharm", "MediPharm Labs" or the "Company") a pharmaceutical company specialized in precision-based cannabinoids, is pleased to announce it has completed the sale of vacant land for net proceeds of $1.9 million dollars.

Read more at prnewswire.com

Provided Content: Content provided by PR Newswire. The Globe and Mail was not involved, and material was not reviewed prior to publication.

More from The Globe

investor newsletter

A change in market leadership may be imminent. Plus, an index-beating U.S. dividend portfolio strategy

Tensions rise in Silicon Valley over sales of startup stocks

inside the market

How pro money managers are balancing exposure to Canadian and U.S. stocks

At the open: North American stock markets rise as rate-cut hopes linger

The close: Wall Street sharply higher as nonfarm payrolls report strengthens case for rate cuts in both the U.S. and Canada

The close: Major North American indexes higher, led by Nasdaq, amid plethora of mixed earnings

international business

Trump awarded 36 million more Trump Media shares worth $1.8-billion after hitting price benchmarks

The close: Stocks mixed as Fed leaves investors guessing as to when rate cuts will arrive